BrainsWay Ltd. (BWAY)
USD 9.08
(-4.32%)
USD 9.08
(-4.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.19 Million USD | 68.56% |
| 2022 | -13.34 Million USD | -106.58% |
| 2021 | -6.46 Million USD | -20.0% |
| 2020 | -5.38 Million USD | 47.86% |
| 2019 | -10.32 Million USD | -59.41% |
| 2018 | -6.47 Million USD | 8.15% |
| 2017 | -7.05 Million USD | -194.28% |
| 2016 | -2.39 Million USD | 41.35% |
| 2015 | -4.08 Million USD | 37.56% |
| 2014 | -6.54 Million USD | 8.1% |
| 2013 | -7.12 Million USD | -20.38% |
| 2012 | -5.91 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 600 Thousand USD | 440.54% |
| 2024 Q1 | 111 Thousand USD | -12.6% |
| 2023 FY | -4.19 Million USD | 68.56% |
| 2023 Q2 | -1.66 Million USD | 31.59% |
| 2023 Q1 | -2.43 Million USD | 37.13% |
| 2023 Q4 | 127 Thousand USD | 155.22% |
| 2023 Q3 | -230 Thousand USD | 86.17% |
| 2022 Q1 | -1.99 Million USD | -47.96% |
| 2022 FY | -13.34 Million USD | -106.58% |
| 2022 Q4 | -3.86 Million USD | 23.26% |
| 2022 Q3 | -5.03 Million USD | -105.67% |
| 2022 Q2 | -2.45 Million USD | -22.93% |
| 2021 Q3 | -1.8 Million USD | 6.91% |
| 2021 Q1 | -2.72 Million USD | -571.92% |
| 2021 FY | -6.46 Million USD | -20.0% |
| 2021 Q2 | -1.93 Million USD | 28.96% |
| 2021 Q4 | -1.34 Million USD | 25.33% |
| 2020 Q2 | -571 Thousand USD | 83.41% |
| 2020 Q4 | -406 Thousand USD | 57.97% |
| 2020 FY | -5.38 Million USD | 47.86% |
| 2020 Q1 | -3.44 Million USD | -48.62% |
| 2020 Q3 | -966 Thousand USD | -69.18% |
| 2019 Q4 | -2.31 Million USD | 12.01% |
| 2019 Q2 | -3.47 Million USD | -82.12% |
| 2019 FY | -10.32 Million USD | -59.41% |
| 2019 Q1 | -1.9 Million USD | 11.26% |
| 2019 Q3 | -2.63 Million USD | 24.22% |
| 2018 Q4 | -2.14 Million USD | -45.5% |
| 2018 Q3 | -1.47 Million USD | 19.11% |
| 2018 FY | -6.47 Million USD | 8.15% |
| 2018 Q2 | -1.82 Million USD | -77.8% |
| 2018 Q1 | -1.02 Million USD | 63.15% |
| 2017 Q2 | -511 Thousand USD | 73.47% |
| 2017 Q4 | -2.78 Million USD | -52.3% |
| 2017 Q3 | -1.83 Million USD | -258.12% |
| 2017 Q1 | -1.92 Million USD | -27.8% |
| 2017 FY | -7.05 Million USD | -194.28% |
| 2016 Q1 | -1.06 Million USD | 36.06% |
| 2016 FY | -2.39 Million USD | 41.35% |
| 2016 Q4 | -1.5 Million USD | -134.74% |
| 2016 Q3 | -642 Thousand USD | -178.48% |
| 2016 Q2 | 818 Thousand USD | 176.74% |
| 2015 FY | -4.08 Million USD | 37.56% |
| 2015 Q4 | -1.66 Million USD | -466.64% |
| 2015 Q3 | -294.21 Thousand USD | 61.93% |
| 2015 Q1 | -5.43 Million USD | -192.72% |
| 2015 Q2 | -772.8 Thousand USD | 85.77% |
| 2014 Q4 | -1.85 Million USD | -156.78% |
| 2014 FY | -6.54 Million USD | 8.1% |
| 2014 Q1 | -11.71 Million USD | -7756.12% |
| 2014 Q3 | -722.55 Thousand USD | 14.71% |
| 2014 Q2 | -847.12 Thousand USD | 92.77% |
| 2013 Q3 | -984.26 Thousand USD | -49.99% |
| 2013 Q4 | -149.09 Thousand USD | 84.85% |
| 2013 FY | -7.12 Million USD | -20.38% |
| 2013 Q1 | -5.3 Million USD | -143.68% |
| 2013 Q2 | -656.22 Thousand USD | 87.63% |
| 2012 Q3 | -1.36 Million USD | 0.0% |
| 2012 FY | -5.91 Million USD | 0.0% |
| 2012 Q4 | -2.17 Million USD | -58.96% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 94.861% |
| Cerus Corporation | -37.48 Million USD | 88.805% |
| OrthoPediatrics Corp. | -20.97 Million USD | 79.99% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 61.69% |
| Talis Biomedical Corporation | -62 Million USD | 93.231% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 69.101% |
| Inogen, Inc. | -102.44 Million USD | 95.903% |
| Spectral AI, Inc. | -20.85 Million USD | 79.874% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 93.094% |
| CVRx, Inc. | -41.19 Million USD | 89.813% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 755.58% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 52.576% |
| Orthofix Medical Inc. | -151.39 Million USD | 97.228% |
| Venus Concept Inc. | -37.25 Million USD | 88.733% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 93.189% |
| Bioventus Inc. | -156.23 Million USD | 97.314% |
| Envoy Medical, Inc. | -29.9 Million USD | 85.967% |
| electroCore, Inc. | -18.83 Million USD | 77.716% |
| IceCure Medical Ltd | -14.65 Million USD | 71.355% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 92.031% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 69.466% |
| MaxCyte, Inc. | -37.92 Million USD | 88.933% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 64.611% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9.717% |
| PAVmed Inc | -64.17 Million USD | 93.46% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 92.001% |
| RxSight, Inc. | -48.6 Million USD | 91.366% |
| Sight Sciences, Inc. | -55.54 Million USD | 92.444% |
| SI-BONE, Inc. | -43.33 Million USD | 90.315% |
| TELA Bio, Inc. | -46.66 Million USD | 91.006% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 92.891% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 91.526% |
| LivaNova PLC | 17.54 Million USD | 123.92% |
| 908 Devices Inc. | -36.39 Million USD | 88.469% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 97.751% |
| Nemaura Medical Inc. | -14.14 Million USD | 70.326% |
| NeuroPace, Inc. | -32.95 Million USD | 87.265% |
| LENSAR, Inc. | -14.38 Million USD | 70.82% |
| Apyx Medical Corporation | -18.71 Million USD | 77.572% |
| Cutera, Inc. | -162.83 Million USD | 97.423% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 61.247% |
| BioSig Technologies, Inc. | -29.04 Million USD | 85.548% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 94.923% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 81.0% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 106.196% |
| Axonics, Inc. | -6.08 Million USD | 31.061% |
| Outset Medical, Inc. | -172.79 Million USD | 97.571% |
| IRIDEX Corporation | -9.57 Million USD | 56.144% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 96.037% |
| IRadimed Corporation | 17.19 Million USD | 124.411% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 49.09% |
| INVO Bioscience, Inc. | -8.03 Million USD | 47.764% |
| Telesis Bio, Inc. | -47.72 Million USD | 91.206% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 140.974% |
| Varex Imaging Corporation | -47.7 Million USD | 91.201% |
| Quipt Home Medical Corp. | -2.78 Million USD | -50.754% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 62.812% |
| Pulmonx Corporation | -60.84 Million USD | 93.102% |
| Dynatronics Corporation | -2.69 Million USD | -55.576% |
| Modular Medical, Inc. | -17.47 Million USD | 75.976% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 63.142% |
| Semler Scientific, Inc. | 20.58 Million USD | 120.391% |
| InMode Ltd. | 197.91 Million USD | 102.121% |
| Bruker Corporation | 427.2 Million USD | 100.982% |
| Cytosorbents Corporation | -28.5 Million USD | 85.278% |
| DexCom, Inc. | 541.5 Million USD | 100.775% |
| Align Technology, Inc. | 445.05 Million USD | 100.943% |
| Viveve Medical, Inc. | -22.02 Million USD | 80.946% |
| ZimVie Inc. | -393.28 Million USD | 98.933% |
| Movano Inc. | -29.28 Million USD | 85.667% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 65.451% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9.717% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 755.58% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 98.115% |
| Profound Medical Corp. | -28.56 Million USD | 85.309% |
| Insulet Corporation | 206.3 Million USD | 102.034% |
| enVVeno Medical Corporation | -23.51 Million USD | 82.153% |
| Surmodics, Inc. | -11.54 Million USD | 63.637% |
| iCAD, Inc. | -4.84 Million USD | 13.41% |
| Nuwellis, Inc. | -20.2 Million USD | 79.232% |
| Biotricity, Inc. | -14.09 Million USD | 70.222% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 96.599% |
| Aethlon Medical, Inc. | -12.2 Million USD | 65.621% |
| InspireMD, Inc. | -19.91 Million USD | 78.926% |
| PAVmed Inc. | -64.17 Million USD | 93.46% |
| BIOLASE, Inc. | -20.63 Million USD | 79.658% |
| Beyond Air, Inc. | -60.24 Million USD | 93.033% |
| FONAR Corporation | 10.56 Million USD | 139.717% |
| AxoGen, Inc. | -21.71 Million USD | 80.673% |
| Vivani Medical, Inc. | -25.65 Million USD | 83.639% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 114.719% |
| Inari Medical, Inc. | -1.63 Million USD | -156.54% |
| UFP Technologies, Inc. | 44.92 Million USD | 109.342% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 18.224% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 36.459% |
| Tenon Medical, Inc. | -15.58 Million USD | 73.063% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 72.793% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 88.122% |
| AdaptHealth Corp. | -678.89 Million USD | 99.382% |
| Sintx Technologies, Inc. | -8.25 Million USD | 49.183% |
| NanoVibronix, Inc. | -3.71 Million USD | -13.096% |
| Quanterix Corporation | -32.33 Million USD | 87.02% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 62.812% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 965.361% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.632% |
| TransMedics Group, Inc. | -25.02 Million USD | 83.231% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 81.037% |
| NeuroMetrix, Inc. | -6.52 Million USD | 35.722% |
| Hyperfine, Inc. | -44.23 Million USD | 90.513% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 94.654% |
| Biomerica, Inc. | -5.97 Million USD | 29.793% |
| Bone Biologics Corporation | -8.94 Million USD | 53.099% |
| AVITA Medical, Inc. | -39.16 Million USD | 89.285% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 57.836% |
| Silk Road Medical, Inc | -55.74 Million USD | 92.471% |